QuickView for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=C367D95CAF574A9239FE4295078310FA;jsessionid=ED732D6F8E2B55D44E4470C64FCAE073;jsessionid=369D0FFBC2D87636BB1B0994D6332FBD;jsessionid=86EE8D8B6B703E6EEBA3A5B918311149;jsessionid=A1D74522D49F2A4AF54A4022A38D48B1;jsessionid=06E70D9D79CEB3A7B96E4A0AECE677FA;jsessionid=9B53035745DA38ECB11D0925A3B55AD5;jsessionid=23A3FEEAB52B6F618D0820B18FD9E403;jsessionid=C6441C138CCC0D30C9C8DA5E6EB2EAD1;jsessionid=953BE87B7EB90277AF024B74BE402E4D;jsessionid=86D7DEE36CB2BF88C584B6A2EC27041D;jsessionid=08B4878A74E857F93C7C9A2D99768DC5;jsessionid=DC0ED87E95425D3B0533DFE6DC3F4DB2 (gene)

1. Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
2. Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
3. Stability of varicella-zoster virus open reading frame 63.
4. Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
5. Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…

There were no clinical trials for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=C367D95CAF574A9239FE4295078310FA;jsessionid=ED732D6F8E2B55D44E4470C64FCAE073;jsessionid=369D0FFBC2D87636BB1B0994D6332FBD;jsessionid=86EE8D8B6B703E6EEBA3A5B918311149;jsessionid=A1D74522D49F2A4AF54A4022A38D48B1;jsessionid=06E70D9D79CEB3A7B96E4A0AECE677FA;jsessionid=9B53035745DA38ECB11D0925A3B55AD5;jsessionid=23A3FEEAB52B6F618D0820B18FD9E403;jsessionid=C6441C138CCC0D30C9C8DA5E6EB2EAD1;jsessionid=953BE87B7EB90277AF024B74BE402E4D;jsessionid=86D7DEE36CB2BF88C584B6A2EC27041D;jsessionid=08B4878A74E857F93C7C9A2D99768DC5;jsessionid=DC0ED87E95425D3B0533DFE6DC3F4DB2